{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:42:40Z","timestamp":1758634960813,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK019986"],"award-info":[{"award-number":["DK019986"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00216-018-1373-3","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T05:08:41Z","timestamp":1537852121000},"page":"7565-7573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ultrafiltration binding analyses of glycated albumin with a 3D-printed syringe attachment"],"prefix":"10.1007","volume":"410","author":[{"given":"Andre D.","family":"Castiaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody W.","family":"Pinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana M.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"1373_CR1","unstructured":"International Diabetes Federation Diabetes Atlas. International Diabetes Federation; 2017."},{"issue":"3","key":"1373_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","volume":"27","author":"SB Williams","year":"1996","unstructured":"Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27(3):567\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1373_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00429099","volume":"35","author":"G McVeigh","year":"1992","unstructured":"McVeigh G, Brennan G, Johnston G, McDermott B, McGrath L, Henry W, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771\u20136.","journal-title":"Diabetologia"},{"key":"1373_CR4","unstructured":"Dugan J, Pfotenhauer K, Young C, Shubrook JH. Diabetes microvascular complications. Primary Care Reports. 2017;23(5)."},{"issue":"3236","key":"1373_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/bmj.1.3236.8","volume":"1","author":"F Banting","year":"1923","unstructured":"Banting F, Campbell W, Fletcher A. Further clinical experience with insulin (pancreatic extracts) in the treatment of diabetes mellitus. Br Med J. 1923;1(3236):8.","journal-title":"Br Med J"},{"issue":"4","key":"1373_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrm782","volume":"3","author":"NJ Bryant","year":"2002","unstructured":"Bryant NJ, Govers R, James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol. 2002;3(4):267.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1373_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1079\/BJN2002763","volume":"89","author":"IS Wood","year":"2003","unstructured":"Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003;89(1):3\u20139.","journal-title":"Br J Nutr"},{"issue":"3","key":"1373_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/diacare.13.3.198","volume":"13","author":"GI Bell","year":"1990","unstructured":"Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, et al. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990;13(3):198\u2013208.","journal-title":"Diabetes Care"},{"issue":"3","key":"1373_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1900\/RDS.2009.6.148","volume":"6","author":"W Medawala","year":"2009","unstructured":"Medawala W, McCahill P, Giebink A, Meyer J, Ku C-J, Spence DM. A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream. Rev Diabet Stud. 2009;6(3):148.","journal-title":"Rev Diabet Stud"},{"key":"1373_CR10","doi-asserted-by":"crossref","unstructured":"Sima AA. Diabetes & C-peptide: scientific and clinical aspects. Springer Science & Business Media; 2011.","DOI":"10.1007\/978-1-61779-391-2"},{"issue":"3789","key":"1373_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1126\/science.157.3789.697","volume":"157","author":"DF Steiner","year":"1967","unstructured":"Steiner DF, Cunningham D, Spigelman L, Aten B. Insulin biosynthesis: evidence for a precursor. Science. 1967;157(3789):697\u2013700.","journal-title":"Science"},{"issue":"5220","key":"1373_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/224697a0","volume":"224","author":"AH Rubenstein","year":"1969","unstructured":"Rubenstein AH, Clark JL, Melani F, Steiner DF. Secretion of proinsulin C-peptide by pancreatic \u03b2 cells and its circulation in blood. Nature. 1969;224(5220):697\u20139.","journal-title":"Nature"},{"key":"1373_CR13","first-page":"A184","volume":"50","author":"MA Cotter","year":"2001","unstructured":"Cotter MA, Cameron NE. C-peptide effects on nerve conduction and blood flow in streptozotocin-induced diabetic rats: modulation by nitric oxide synthase inhibition. Diabetes. 2001;50:A184.","journal-title":"Diabetes"},{"issue":"7","key":"1373_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s001250100570","volume":"44","author":"AAF Sima","year":"2001","unstructured":"Sima AAF, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, et al. C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB\/Wor rat. Diabetologia. 2001;44(7):889\u201397.","journal-title":"Diabetologia"},{"issue":"5","key":"1373_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1039\/C4IB00243A","volume":"7","author":"Y Liu","year":"2015","unstructured":"Liu Y, Chen C, Summers S, Medawala W, Spence DM. C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device. Integr Biol. 2015;7(5):534\u201343.","journal-title":"Integr Biol"},{"issue":"8","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1039\/C7MB00199A","volume":"13","author":"CW Pinger","year":"2017","unstructured":"Pinger CW, Entwistle K, Bell T, Liu Y, Spence D. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? Mol BioSyst. 2017;13(8):1432\u20137.","journal-title":"Mol BioSyst"},{"issue":"1","key":"1373_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00125-007-0853-3","volume":"51","author":"JA Meyer","year":"2008","unstructured":"Meyer JA, Froelich JM, Reid GE, Karunarathne WK, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia. 2008;51(1):175\u201382.","journal-title":"Diabetologia"},{"issue":"4","key":"1373_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/dc15-2068","volume":"39","author":"J Wahren","year":"2016","unstructured":"Wahren J, Foyt H, Daniels M, Arezzo JC. Long-acting C-peptide and neuropathy in type 1 diabetes: a 12-month clinical trial. Diabetes Care. 2016;39(4):596\u2013602.","journal-title":"Diabetes Care"},{"issue":"14","key":"1373_CR19","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1021\/acs.analchem.7b01848","volume":"89","author":"CW Pinger","year":"2017","unstructured":"Pinger CW, Heller AA, Spence DM. A printed equilibrium dialysis device with integrated membranes for improved binding affinity measurements. Anal Chem. 2017;89(14):7302\u20136.","journal-title":"Anal Chem"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jps.2600740625","volume":"74","author":"JW Melten","year":"1985","unstructured":"Melten JW, Wittebrood AJ, Willems HJ, Faber GH, Wemer J, Faber DB. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin. J Pharm Sci. 1985;74:692\u20134.","journal-title":"J Pharm Sci"},{"issue":"17\u201318","key":"1373_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.cca.2011.05.012","volume":"412","author":"OS Barnaby","year":"2011","unstructured":"Barnaby OS, Cerny RL, Clarke W, Hage DS. Quantitative analysis of glycation patterns in human serum albumin using 16O\/18O-labeling and MALDI\u2013TOF MS. Clin Chim Acta. 2011;412(17\u201318):1606\u201315.","journal-title":"Clin Chim Acta"},{"key":"1373_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","volume":"425","author":"J Anguizola","year":"2013","unstructured":"Anguizola J, Matsuda R, Barnaby OS, Hoy KS, Wa C, DeBolt E, et al. Review: glycation of human serum albumin. Clin Chim Acta. 2013;425:64\u201376.","journal-title":"Clin Chim Acta"},{"key":"1373_CR23","unstructured":"Hage DS. Analysis of biological interactions by affinity chromatography: clinical and pharmaceutical applications. Clin Chem. 2017;clinchem. 2016.262253."},{"issue":"3\u20134","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cca.2010.10.018","volume":"412","author":"OS Barnaby","year":"2011","unstructured":"Barnaby OS, Cerny RL, Clarke W, Hage DS. Comparison of modification sites formed on human serum albumin at various stages of glycation. Clin Chim Acta. 2011;412(3\u20134):277\u201385.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"1373_CR25","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s00216-011-5382-8","volume":"401","author":"R Matsuda","year":"2011","unstructured":"Matsuda R, Anguizola J, Joseph K, Hage DS. High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin. Anal Bioanal Chem. 2011;401(9):2811.","journal-title":"Anal Bioanal Chem"},{"issue":"9","key":"1373_CR26","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.biochi.2012.05.017","volume":"94","author":"J Baraka-Vidot","year":"2012","unstructured":"Baraka-Vidot J, Guerin-Dubourg A, Bourdon E, Rondeau P. Impaired drug-binding capacities of in vitro and in vivo glycated albumin. Biochimie. 2012;94(9):1960\u20137.","journal-title":"Biochimie"},{"issue":"4","key":"1373_CR27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","volume":"93","author":"P Rondeau","year":"2011","unstructured":"Rondeau P, Bourdon E. The glycation of albumin: structural and functional impacts. Biochimie. 2011;93(4):645\u201358.","journal-title":"Biochimie"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-1373-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1373-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:59:22Z","timestamp":1662137962000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-1373-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":27,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-1373-3","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"type":"print","value":"1618-2642"},{"type":"electronic","value":"1618-2650"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}